Biomatics closes new fund at $300M

Biomatics Capital Partners closed its second fund at $300 million and added Mike Poole and Errik Anderson as venture partners (see "Biomatics' Next Phase").

Fund II will invest in 15-20 healthcare companies across therapeutics, diagnostics, enabling R&D technologies and data-driven clinical practice tools. It will focus on early stage investments and provide up to $30 million per company. The firm may also invest in later-stage rounds...